China Resources Sanjiu Medical & Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Nov 18
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results
Aug 26Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?
Aug 09Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Jul 12China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50
Jun 09China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 23An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued
Apr 16Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Mar 20Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?
Feb 28CEO
China Resources Sanjiu Medical & Pharmaceutical has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | less than a year | CN¥1.88m | no data | |
| CFO & Secretary of the Board of Directors | 5.2yrs | CN¥2.49m | 0.013% CN¥ 7.7m | |
| VP, General Counsel | 13.3yrs | CN¥3.10m | 0.013% CN¥ 7.9m | |
| Vice President | no data | CN¥2.67m | 0.010% CN¥ 6.0m |
5.2yrs
Average Tenure
47.5yo
Average Age
Experienced Management: 000999's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | less than a year | CN¥1.88m | no data | |
| VP, General Counsel | 19.7yrs | CN¥3.10m | 0.013% CN¥ 7.9m | |
| Chairman | 7.3yrs | CN¥4.61m | 0.019% CN¥ 11.5m | |
| Independent Director | 6.7yrs | CN¥150.00k | no data | |
| Independent Director | 6.7yrs | CN¥150.00k | no data | |
| Chairman of the Supervisory Board | 6.1yrs | no data | no data | |
| Non-Employee Supervisor | 5.5yrs | no data | no data | |
| Independent Director | 1.3yrs | no data | no data | |
| Non-Independent Director | 2.8yrs | no data | no data | |
| Non-Independent Director | 2.8yrs | no data | no data | |
| Director | 3.1yrs | CN¥150.00k | no data | |
| Director | 2.2yrs | no data | no data |
4.3yrs
Average Tenure
56yo
Average Age
Experienced Board: 000999's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:29 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is covered by 42 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Changming He | BOCI Research Ltd. |
| Jessica Li | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |